AQMS underwent a major debt restructuring while dramatically scaling up R&D investments, with debt falling 96% and R&D expenses surging 493%.
The massive debt reduction from $9.3M to $332K represents either a major debt restructuring, conversion to equity, or debt forgiveness that fundamentally changed the company's capital structure. The simultaneous 493% increase in R&D spending to $8.1M signals aggressive investment in their battery recycling technology development, though this contributed to continued operating losses.
The company's financial profile transformed dramatically with current assets nearly tripling to $13.4M (driven by 165% cash increase to $10.8M) while total debt plummeted 96% to just $332K, suggesting either significant new equity financing or major debt restructuring. R&D expenses exploded 493% to $8.1M while capital expenditures dropped 95% to $425K, indicating a shift from facility buildout to technology development, though operating cash flow remained deeply negative at -$10.3M. The overall picture suggests AQMS secured substantial new funding to eliminate debt burden and accelerate R&D, but investors should monitor cash burn rates given the significant operating losses.
R&D investment increased 492.8% — signals commitment to future product development, though near-term margin impact.
Interest expense surged 396.8% — significant debt increase or rising rates materially impacting earnings.
Current assets grew 188.7% — improving short-term liquidity or inventory/receivables build.
Cash position surged 165% — strong cash generation or capital raise providing significant financial cushion.
Debt reduced 96.4% — deleveraging strengthens balance sheet and reduces financial risk.
Capex reduced 94.6% — investment cycle winding down or capital discipline; may improve near-term free cash flow.
Liabilities reduced 51.2% — deleveraging improves balance sheet strength and financial flexibility.
Current liabilities reduced — improved short-term financial position and working capital health.
Total assets contracted 25.3% — asset sales, write-downs, or balance sheet optimization underway.
Operating cash flow grew 24.8% — strong conversion of earnings to cash, healthy business fundamentals.
See what changed in your portfolio's filings
500+ US-listed companies analyzed. Language delta, financial analysis, instant signal scoring.
Try Tracenotes free →